Objective-To study the circadian pattern of plasma concentrations of vasoactive intestinal peptide (VIP) in patients with orthotopic heart transplants. Circulating VIP is known to have neural and immunological sources. Patients and methods-13 patients with orthotopic heart transplants were studied 12-53 months (mean 318 months) after operation. All were haemodynamically compensated and had no histological evidence of rejection. They were being treated with cyclosporin, azathioprine, and prednisone. Ten healthy individuals were studied as controls. Circulating VIP was assayed six times within a 24h period. Time qualified data were analysed by ANOVA and the cosinor method. Student's t test for unpaired data and Bingham's test for cosinorderived parameters were used for statistical comparisons. Results-Plasma concentrations of VIP were lower in the patients with orthotopic heart transplants than in the controls (p < 0.001). ANOVA and the cosinor method respectively showed a statistically significant within-day variability and circadian rhythm in the controls but not in the patients with heart transplants.
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Discussion-The low plasma concentrations of VIP in the patients with heart transplants could be the result of the lack of contribution by the cardiac VlPergic fibres, a reduction of VIP release by the pharmacologically suppressed immune system, the inhibitory effects of cyclosporin on neural fimction and humoral secretions, and the effects of negative feedback on VIP release of high concentrations of atrial natriuretic peptide. The lack of the circadian rhythm suggests a structural disorder, which should be firther investigated. (Br HeartrJ 1993; 70:363-365) Vasoactive intestinal peptide (VIP) is widely distributed throughout the central and peripheral nervous system where it acts as a neurotransmitter or neuromodulator or both.1-11 The cardiovascular system of various mammalian species is innervated by VIP fibres, which are more dense in the sinoatrial node, atrioventricular node, atrial myocardium, and epicardial coronary arteries and less dense in the ventricular myo-cardium.12-"5 The physiological role of endo-genous VIP in the cardiovascular system has not been clearly established. In adult animals and humans intravenous VIP causes vasodilatation of the systemic and coronary arteries and has positive inotropic and chronotropic effects.l6- 22 VIP is assumed to be a neurotransmitter rather than a bloodborne hormone and its circulating concentrations probably represent an overflow of the neuronal release. Plasma concentrations of VIP were increased in severe hepatic failure23 and cardiac failure2425 but unchanged in patients with circulatory shock24 or myocardial infarction. 24 Patients with heart transplants show abnormal circulating concentrations or circadian rhythmicity or both of the hormones responsible for the regulation of the cardiovascular system.26
In the present study we investigated the hypothesis that, like other vasoactive peptides, VIP release is also impaired. We used a chronobiological protocol for this study because plasma concentrations of VIP show a circadian rhythm.27
Patients and methods We studied 13 patients with orthotopic heart transplants (10 men and 3 women, aged 27-56 years) who were haemodynamically compensated. They all had transplantation because of refractory congestive heart failure (New York Heart Association grade IV) caused by primary dilated cardiomyopathy. 
